// App-Quantinova.ai

: Prospective, Open-Label Study Evaluating the Safety and Tolerability of Higher Infusion Rates of Intravenous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy. Interim analyses. (P2.4-028)

Researchers

Presenter

  • Yue Jiang

Principal Investigators

  • Vera Bril

  • Christine Heung

  • Shabber Mannan

  • Eduardo Ng

  • Evelyn Sarpong

  • Jafar Shabanpour

  • Carolina Barnett

Medical Centers

  • Toronto Western Hospital, Toronto, ON, Canada

  • University Health Network Kingston ON Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Inflammatory demyelinating polyneuropathy

Biomarkers

  • N/A

Drug/Treatment

  • IVIG

Outcome

  • N/A

Study Design

  • Open Label

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved